Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2025 investor letter. A ...

McKesson is a Strong Buy with growth in oncology and biopharma, 19% revenue surge, and a focus on high-growth pharma markets.

From AI for clinical documentation to imaging, health system CIOs have been busy investing in emerging technologies to improve patient care and help providers become more efficient. Becker’s asked ...